+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Byetta"

From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Byetta - API Insight, 2022 - Product Thumbnail Image

Byetta - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Byetta- Drug Insight, 2019 - Product Thumbnail Image

Byetta- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Loading Indicator

Byetta is a brand of exenatide, a drug used to treat type 2 diabetes. It is a member of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. Byetta is an injectable medication that helps to control blood sugar levels by increasing the amount of insulin released by the pancreas. It is typically used in combination with other diabetes medications. The Endocrine and Metabolic Disorders Drugs market is a large and growing market, with a wide range of products available. Byetta is one of the most popular drugs in this market, and is used by millions of people around the world. Companies in the Byetta market include Eli Lilly, Novo Nordisk, Sanofi, Merck, and AstraZeneca. Show Less Read more